What Birchview Capital, LP reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1618205 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 297.2K |
| −2.9% |
| $17.1M |
| 8% |
LRCXLAM Research Corp | 35K | −2.8% | $15.2M | 7.1% |
SLDBSolid Biosciences Inc. | 666.2K | +6.4% | $6.7M | 3.1% |
NTLAIntellia Therapeutics, Inc. | 385.4K | −13.5% | $6.5M | 3% |
BIODESIX INCCOM | 286.8K | ±0% | $6.5M | 3% |
STOKStoke Therapeutics, Inc. | 178.1K | −15.2% | $5.8M | 2.7% |
OVVOvintiv Inc. | 107.5K | ±0% | $5.7M | 2.6% |
NKTRNektar Therapeutics | 81K | +161.3% | $5.7M | 2.6% |
CORTCorcept Therapeutics Inc | 57.2K | +21.2% | $5M | 2.3% |
NBIXNeurocrine Biosciences Inc | 27.2K | ±0% | $4.6M | 2.1% |
PRTAProthena Corp Public Ltd Co | 449K | ±0% | $4.4M | 2.1% |
ACADAcadia Pharmaceuticals Inc | 171K | ±0% | $4.3M | 2% |
PTGXProtagonist Therapeutics, Inc | 35K | +0.1% | $4.3M | 2% |
CMPXCompass Therapeutics, Inc. | 1.7M | +14.3% | $3.7M | 1.7% |
RLMDRelmada Therapeutics, Inc. | 408.1K | −0.3% | $2.8M | 1.3% |
ALKSAlkermes plc. | 50K | ±0% | $2.6M | 1.2% |
HALOHalozyme Therapeutics, Inc. | 33.3K | +229.2% | $2.6M | 1.2% |
CLDXCelldex Therapeutics, Inc. | 69.9K | −0.3% | $2.6M | 1.2% |
CYTKCytokinetics Inc | 30K | ±0% | $2.6M | 1.2% |
OLMAOlema Pharmaceuticals, Inc. | 199K | −9.1% | $2.5M | 1.2% |
VERAVera Therapeutics, Inc. | 57.8K | +31.3% | $2.5M | 1.2% |
UTHRUNITED THERAPEUTICS Corp | 4.5K | +0.1% | $2.4M | 1.1% |
ZBIOZenas BioPharma, Inc. | 93.6K | +33.7% | $2.4M | 1.1% |
QUREuniQure N.V. | 50.7K | −49.7% | $2.3M | 1.1% |
PACBPacific Biosciences of California, Inc. | 1.4M | −10.0% | $2.3M | 1.1% |
ABVXAbivax S.A. | 17K | New | $2.3M | 1.1% |
VIRVir Biotechnology, Inc. | 220K | New | $2.2M | 1% |
BIIBBiogen Inc. | 9K | +80.0% | $1.9M | 0.9% |
EQTEQT Corp | 34.6K | ±0% | $1.8M | 0.9% |
BIOABioAge Labs, Inc. | 69K | New | $1.7M | 0.8% |
TVTXTravere Therapeutics, Inc. | 29K | −0.7% | $1.6M | 0.8% |
QUIDELORTHO CORPCOM | 89.4K | +8.3% | $1.6M | 0.7% |
AXSMAxsome Therapeutics, Inc. | 6K | ±0% | $1.5M | 0.7% |
FHTXFoghorn Therapeutics Inc. | 281.9K | +0.1% | $1.4M | 0.6% |
BCYCBicycle Therapeutics PLC | 313.6K | −32.4% | $1.3M | 0.6% |
GPCRStructure Therapeutics Inc. | 24K | −76.0% | $1.3M | 0.6% |
XENEXenon Pharmaceuticals Inc. | 21K | +0.2% | $1.3M | 0.6% |
NVONovo Nordisk a S | 24K | New | $1.2M | 0.5% |
FCXFreeport-McMoran Inc | 18K | −0.0% | $1.1M | 0.5% |
IMNMImmunome Inc. | 50K | ±0% | $1.1M | 0.5% |
PHVSPharvaris N.V. | 29.8K | ±0% | $1M | 0.5% |
HROWHarrow, Inc. | 24K | ±0% | $1M | 0.5% |
ADAGAdagene Inc. | 240K | New | $1M | 0.5% |
DFTXDefinium Therapeutics, Inc. | 20K | New | $940.8K | 0.4% |
SLNSilence Therapeutics plc | 71.2K | New | $782K | 0.4% |
BBIOBridgeBio Pharma, Inc. | 8.7K | +0.6% | $651K | 0.3% |
FDMT4D Molecular Therapeutics, Inc. | 48.5K | New | $645.1K | 0.3% |
URGNUroGen Pharma Ltd. | 16.5K | New | $606.7K | 0.3% |
PHATPhathom Pharmaceuticals, Inc. | 55K | −71.8% | $596.8K | 0.3% |
CAMPCamp4 Therapeutics Corp | 120K | New | $524.4K | 0.2% |
SVRASavara Inc | 80K | New | $492.8K | 0.2% |
CADLCandel Therapeutics, Inc. | 47.8K | −20.4% | $491.9K | 0.2% |
ALTAltimmune, Inc. | 152.7K | New | $464.2K | 0.2% |
CMPSCOMPASS Pathways plc | 30K | −92.0% | $424.5K | 0.2% |
KARYOPHARM THERAPEUTICS INCCOM | 43K | −48.8% | $419.6K | 0.2% |
CGEMCullinan Therapeutics, Inc. | 20K | ±0% | $364.2K | 0.2% |
TRINTrinity Capital Inc. | 20K | ±0% | $357.8K | 0.2% |
CAPRCapricor Therapeutics, Inc. | 14.4K | New | $345.6K | 0.2% |
CSTLCastle Biosciences Inc | 13K | +0.7% | $309.7K | 0.1% |
IVVDInvivyd, Inc. | 342.3K | New | $298.6K | 0.1% |
GRCEGrace Therapeutics, Inc. | 120K | +140.0% | $272.4K | 0.1% |
KBDCKayne Anderson BDC, Inc. | 20K | ±0% | $270.6K | 0.1% |
VYGRVoyager Therapeutics, Inc. | 75.1K | +0.3% | $263K | 0.1% |
LUNGPulmonx Corp | 200.5K | −19.9% | $260.7K | 0.1% |
NTLAIntellia Therapeutics, Inc. | 500 | New | $260K | 0.1% |
OCULOcular Therapeutix, Inc | 20.7K | −93.5% | $202.8K | 0.1% |
KYNBKyntra Bio, Inc. | 22.6K | ±0% | $170.4K | 0.1% |
ELUTElutia Inc. | 165.1K | ±0% | $161.7K | 0.1% |
QNRXQuoin Pharmaceuticals Ltd. | 20K | ±0% | $96.8K | 0.1% |
LPCNLipocine Inc. | 16.7K | −85.1% | $42.8K | 0.1% |
DCGODocGo Inc. | 39.1K | −1.3% | $20.2K | 0.1% |
GOSSGossamer Bio, Inc. | 18.2K | ±0% | $3K | 0.1% |
